Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neogenomics Inc 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 USA

P: 239-768-0600 F: 239-690-4237

Description:

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.

Key Statistics

Overview:

Market Capitalization, $K 5,798,558
Shares Outstanding, K 117,048
Annual Sales, $ 444,450 K
Annual Net Income, $ 4,170 K
Last Quarter Sales, $ 126,000 K
Last Quarter Net Income, $ 15,420 K
60-Month Beta 0.68
% of Insider Shareholders 6.50%
% of Institutional Shareholders 88.81%
Float, K 109,440
% Float 93.50%

Growth:

1-Year Return 76.65%
3-Year Return 434.41%
5-Year Return 591.90%
5-Year Revenue Growth 345.34%
5-Year Earnings Growth 250.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.14 on 02/24/21
Next Earnings Date 05/05/21
Earnings Per Share ttm 0.07
EPS Growth vs. Prev Qtr 200.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

NEO Ratios

Ratio
Price/Earnings ttm 702.71
Price/Earnings forward 176.39
Price/Earnings to Growth 15.36
Return-on-Equity % 1.46%
Return-on-Assets % 1.01%
Profit Margin % 0.94
Net Margin % N/A
Debt/Equity 0.24
Price/Sales 12.95
Price/Cash Flow 111.53
Price/Book 7.92
Book Value/Share 6.25
Interest Coverage -1.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar